Harnessing the Full Potential of Protein Degradation through Identification of Novel Targets

Home: Welcome

Our Purpose

f5 Therapeutics is a privately held, pharmaceutical company that focuses on targeted protein degradation via ‘molecular glues.’ Our NExMod™ (Neosubstrate Expression Modulators) platform focuses on discovering novel targets for degradation to combat human disease across multiple therapeutic areas. Utilizing our proprietary methods, we have discovered multiple novel neosubstrates with the potential to revolutionize cancer care.

Our Approach

Targeted protein degradation represents a unique drug discovery approach to disrupt disease causing proteins, that are intractable to conventional therapeutics.

Learn More

Pipeline

f5 Therapeutics is advancing assets towards a diverse set of novel targets that will provide hope to patients who face limited treatment options.

Learn More

Team

f5 Therapeutics was co-founded by experienced veterans of the healthcare industry with a proven track record of drug discovery execution and commercialization success.

Learn More

Home: Products